
Our Story
Irish By Origin. Global By Impact.
Founded in 2005, Eirgen Pharma has grown into a global leader in developing and manufacturing high-potency medicines. We specialize in softgel capsules, film-coated tablets, and powder or liquid-filled hard-shell capsules.
​
We focus on complex pharmaceuticals, especially oncology therapies, and are proud to be a trusted CDMO and CMO partner to many of the world's top pharmaceutical companies.
​
Since becoming part of the OPKO Health family in 2015, we've expanded both our R&D capabilities and GMP-compliant manufacturing facilities. Our newest facility - launching in Q3 of 2025 - will allow for an additional 1-billion-unit capacity by 2027, strengthening our ability to deliver innovation, meet global regulatory standards (FDA, EMA, HPRA, PMDA), and support customers worldwide with a robust supply chain.
​
Under the leadership of Chief Executive Officer, Damien Burke, Eirgen Pharma now supplies life-changing medicines to patients in over 60 countries, including the United States, Europe, Japan, Canada, the Middle East, Australia, and Africa.



Our Mission
To provide innovative development, manufacturing, and packaging solutions to our partners, enabling them to bring high-quality medicines to patients worldwide.
Achieving Excellence, Together.
Our Vision
At Eirgen Pharma our ultimate purpose is clear: to improve patients' lives. We strive to make a meaningful difference in the lives of patients around the world.
oUR PARTNERS
At Eirgen Pharma, partnership is at the heart of everything we do. We approach each collaboration with a strong foundation of trust, open communication, responsiveness, and adaptability - principles that guide every project we undertake. This dedication to true partnership, combined with our unwavering commitment and impeccable inspection record, is why many of the world's leading pharmaceutical and biotech companies choose Eirgen as their trusted development and manufacturing partner.

Connect With Our Leadership Team
Behind every complex formulation and every successful launch is a team of dedicated experts.
Our leadership combines deep industry expertise with a hands-on approach to help you solve complex challenges, scale fast, and deliver high-quality medicines - safely and globally.